6

SXTP

60 degrees pharmaceuticals, Inc.

2.39

0.13+5.75%
After Hours: 2.370  -0.02  -0.84%19:54 05/09 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

681.35K

253.57K

511.21K

6.35M

2.18M

Net Income

-7.95M

-3.77M

-6.18M

-4.25M

-3.03M

ROE

-1.8158

0.3892

0.2923

0.2347

--

ROA

-1.1736

-0.8294

-4.5948

-2.1261

--

EPS

-18.5455

-60.4003

-66.5918

-45.8015

-32.6841

BVPS

7.1186

50.2957

-254.005

-189.3594

-188.5534

Asset Turnover

0.1006

0.0558

0.38

3.1768

--

Debt-to-Asset

0.3133

0.3836

19.6162

14.0277

7.9342

Current Ratio

3.2502

2.5543

0.0459

1.8517

1.7043

Quick Ratio

2.983

2.3899

0.0243

0.7674

0.979